West Pharmaceutical Services (WST) Market Capitalization (2009 - 2026)

West Pharmaceutical Services has disclosed Market Capitalization across 18 years of filings, most recently posting $25.3 billion for Q2 2026.

• In Q2 2026, Market Capitalization rose 60.65% year-over-year to $25.3 billion; the TTM figure through Jun 2026 stood at $25.3 billion (up 60.65% YoY), while the FY2025 annual figure was $19.8 billion, down 16.35% from the prior year.
• Market Capitalization came in at $25.3 billion for Q2 2026 at West Pharmaceutical Services, up from $17.8 billion in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $30.4 billion in Q1 2022 to a low of $15.7 billion in Q2 2025.
• Average Market Capitalization over 5 years is $22.7 billion, with a median of $23.0 billion recorded in 2022.
• Year-over-year, Market Capitalization plunged 49.89% in 2022 and jumped 60.65% in 2026.
• Over 5 years, Market Capitalization stood at $17.4 billion in 2022, then soared by 48.4% to $25.9 billion in 2023, then slipped by 8.49% to $23.7 billion in 2024, then decreased by 16.35% to $19.8 billion in 2025, then increased by 27.58% to $25.3 billion in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $25.3 billion in Q2 2026, $17.8 billion in Q1 2026, and $19.8 billion in Q4 2025.